# OnCo record swog-s1815 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/swog-s1815/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "swog-s1815", "NCT03768414" ;
  schema:name "SWOG S1815"@en ;
  schema:alternateName "S1815"@en ;
  schema:description "Adding a third chemotherapy drug, nab-paclitaxel, to gemcitabine and cisplatin did not help people with advanced bile duct or gallbladder cancer live longer in this 452-patient US trial, although the gallbladder subgroup showed a hint of slower progression that needs its own test."@en ;
  schema:url <https://onco.cc/trials/swog-s1815/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03768414>, <https://doi.org/10.1200/JCO-24-01383> ;
  onco:status "negative" ;
  onco:tag "failure" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-cisplatin/>, <https://onco.cc/drugs/nab-paclitaxel/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/cisplatin/> .